On Wednesday (June 19), Statistics Canada issued two reports on the impact the marijuana industry is having in the country.

In the first report, the Government of Canada says it earned C$186 million from taxes on legal marijuana products in the first five and a half months after the legalization of recreational use on October 17.


In 2019 alone, the government has collected a total of C$107.1 million from general and excise taxes at both the federal and provincial levels.

The provinces have accumulated C$79 million in excise taxes, while the federal government has raked in excise tax revenue of C$19 million so far in 2019.

In its release, the government indicates that revenue from general taxes is expected to rise for the remainder of 2019 as more cannabis stores open their doors across the country.

The second report from the government relates to consumer trends and market preferences so far. This study was based on self-reported data.

According to Statistics Canada, the rate of cannabis use in Canada went up from 14 percent to 18 percent between 2018 and 2019.

The report indicates that the average age of a marijuana consumer in Canada was 38 years old as of early 2019.

Given its prominence in the marketplace, dried flower remains the top used product in the new legalized market, with an average of 28 grams consumed per person over a three month period.

The government reported that 84.2 percent of consumers use dried flower and 45 percent claim to only use this product.

The increase in consumers was also represented by a rise in the percentage of male users. The study found that 46.4 percent of males aged 18 to 24, 30.5 percent of males aged 25 to 44 and 16.1 percent of males aged 45 to 64 consume cannabis.

The government agency indicated surprise at the percentage of reported use of cannabis over the first three months of 2019 from residents of Ontario and Alberta. Numbers in those provinces came in at 21.5 percent and 20 percent, respectively, much higher than in the rest of Canada.

However, Quebec and Manitoba reported lower-than-average use, according to the report, with 11 and 13 percent respectively.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

NYSE | TSX: ACB

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less